GE Healthcare Advances the Future of Precision Medicine in Oncology with New Technology Partners at #ASCO22
GE Healthcare Advances the Future of Precision Medicine in Oncology with New Technology Partners at #ASCO22
Source: ge.com
📰 Data Driven Medicine News
Data Driven Medicine News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Data Driven Medicine. Real-time updates on events, politics, business and more.
GE Healthcare Advances the Future of Precision Medicine in Oncology with New Technology Partners at
Collaborations demonstrate role as a core partner in multidisciplinary cancer careCHICAGO--(BUSINESS WIRE)--From early detection to remote monitoring and data sharing, GE Healthcare’s innovative suite of diagnostic and treatment technologies are designed to help improve detection, clinical efficiency, operational ef...
Source: pharmiweb.com
GE Healthcare Advances the Future of Precision Medicine in Oncology with New Technology Partners at #ASCO22 - Press Release
Collaborations demonstrate role as a core partner in multidisciplinary cancer care From early detection to remote monitoring and data sharing, GE Heal
Source: wiredprnews.com
SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research
The intended collaboration aims to help improve patient care by enhancing next-generation sequencing research for cancer care and expanding data s...
United States Jurgi Camblong Homologous Recombination Deficiency Ambry Genetics Ambry Genetic Variant Assessment Data Driven Medicine
Source: businessinsider.com
SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research
The intended collaboration aims to help improve patient care by enhancing next-generation sequencing research for cancer care and expanding data sources for precision medicine. BOSTON, ALISO VIEJO, Calif. and LAUSANNE, Switzerland, March 14, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) and REALM IDx announced today that they signed a letter of intent to collaborate in the co-development of...
Source: asiaone.com
SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research
/PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) and REALM IDx announced today that they signed a letter of intent to collaborate in the co-development of novel...
Source: prnewswire.com
SOPHiA GENETICS Launches New Deep Learning Capabilities to Support the Detection of Homologous Recombination Deficiencies
/PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, announced today the launch of their SOPHiA DDM Homologous Recombination...
United States Kristina Rodnikova Jurgi Camblong Research Use Data Driven Medicine Recombination Deficiency
Source: prnewswire.com
Institut Paoli Calmettes Extends Partnership with SOPHiA GENETICS
/PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, have announced, in conjunction with Assises de Génétique, an extension of...
United States Institut Paoli Calmettes Jurgi Camblong Reference Medical Biology Laboratory Exchange Commission Research Use
Source: prnewswire.com
SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study
/PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine,...
Source: prnewswire.com
SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study
/PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine,...
Source: prnewswire.com